» Articles » PMID: 36625629

Live Cell Lineage Tracing of Dormant Cancer Cells

Overview
Date 2023 Jan 10
PMID 36625629
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is a leading cause of global cancer-related deaths, and metastasis is the overwhelming culprit of poor patient prognosis. The most nefarious aspect of metastasis is dormancy, a prolonged period between primary tumor resection and relapse. Current therapies are insufficient at killing dormant cells; thus, they can remain quiescent in the body for decades until eventually undergoing a phenotypic switch, resulting in metastases that are more adaptable and drug resistant. Unfortunately, dormancy has few in vitro models, largely because lab-derived cell lines are highly proliferative. Existing models address tumor dormancy, not cellular dormancy, because tracking individual cells is technically challenging. To combat this problem, a live cell lineage approach to find and track individual dormant cells, distinguishing them from proliferative and dying cells over multiple days, is adapted. This approach is applied across a range of different in vitro microenvironments. This approach reveals that the proportion of cells that exhibit long-term quiescence is regulated by both cell intrinsic and extrinsic factors, with the most dormant cells found in 3D collagen gels. This paper envisions that this approach will prove useful to biologists and bioengineers in the dormancy community to identify, quantify, and study dormant tumor cells.

Citing Articles

Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis.

Bakhshandeh S, Heras U, Taieb H, Varadarajan A, Lissek S, Hucker S Sci Adv. 2024; 10(45):eadr3997.

PMID: 39504377 PMC: 11540038. DOI: 10.1126/sciadv.adr3997.


Outlook and opportunities for engineered environments of breast cancer dormancy.

Richbourg N, Irakoze N, Kim H, Peyton S Sci Adv. 2024; 10(10):eadl0165.

PMID: 38457510 PMC: 10923521. DOI: 10.1126/sciadv.adl0165.


COLLAGEN MINERALIZATION DECREASES NK CELL-MEDIATED CYTOTOXICITY OF BREAST CANCER CELLS VIA INCREASED GLYCOCALYX THICKNESS.

Park S, Choi S, Shimpi A, Estroff L, Fischbach C, Paszek M bioRxiv. 2024; .

PMID: 38328161 PMC: 10849468. DOI: 10.1101/2024.01.20.576377.


Collagen Mineralization Decreases NK Cell-Mediated Cytotoxicity of Breast Cancer Cells via Increased Glycocalyx Thickness.

Park S, Choi S, Shimpi A, Estroff L, Fischbach C, Paszek M Adv Mater. 2024; 36(43):e2311505.

PMID: 38279892 PMC: 11471288. DOI: 10.1002/adma.202311505.


Structurally decoupled stiffness and solute transport in multi-arm poly(ethylene glycol) hydrogels.

Richbourg N, Peppas N Biomaterials. 2023; 301:122272.

PMID: 37573839 PMC: 10785603. DOI: 10.1016/j.biomaterials.2023.122272.


References
1.
Rak J, McEachern D, Miller F . Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia. Br J Cancer. 1992; 65(5):641-8. PMC: 1977372. DOI: 10.1038/bjc.1992.138. View

2.
Malladi S, Macalinao D, Jin X, He L, Basnet H, Zou Y . Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell. 2016; 165(1):45-60. PMC: 4808520. DOI: 10.1016/j.cell.2016.02.025. View

3.
Barney L, Hall C, Schwartz A, Parks A, Sparages C, Galarza S . Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Sci Adv. 2020; 6(11):eaaz4157. PMC: 7065904. DOI: 10.1126/sciadv.aaz4157. View

4.
Ruud K, Hiscox W, Yu I, Chen R, Li W . Distinct phenotypes of cancer cells on tissue matrix gel. Breast Cancer Res. 2020; 22(1):82. PMC: 7395363. DOI: 10.1186/s13058-020-01321-7. View

5.
Naumov G, MacDonald I, Weinmeister P, Kerkvliet N, Nadkarni K, Wilson S . Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002; 62(7):2162-8. View